DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹794 Cr | ₹715 Cr | ₹1,509 Cr | ₹761 Cr | ₹1,150 Cr |
What is the latest Short Term Loans and Advances ratio of DIVIS LABORATORIES ?
Year | Short Term Loans and Advances |
---|---|
Mar2024 | ₹794 Cr |
Mar2023 | ₹715 Cr |
Mar2022 | ₹1,509 Cr |
Mar2021 | ₹761 Cr |
Mar2020 | ₹1,150 Cr |
How is Short Term Loans and Advances of DIVIS LABORATORIES Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2024 | ₹794 Cr | 11.05 | |
Mar2023 | ₹715 Cr | -52.63 | |
Mar2022 | ₹1,509 Cr | 98.37 | |
Mar2021 | ₹761 Cr | -33.85 | |
Mar2020 | ₹1,150 Cr | - |
Compare Short Term Loans and Advances of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹153,275.8 Cr | -2.3% | 0.8% | 72.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,393.0 Cr | -2.8% | 7.6% | 8.4% | Stock Analytics | |
CIPLA | ₹116,434.0 Cr | -5.4% | -1.5% | 0.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,474.0 Cr | -0.8% | 6.8% | 25.6% | Stock Analytics | |
MANKIND PHARMA | ₹99,974.0 Cr | 2.1% | 3.7% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,465.9 Cr | -5.5% | 1.6% | -5.1% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2.3% |
0.8% |
72.7% |
SENSEX | 0.7% |
4% |
6.3% |
You may also like the below Video Courses